共 135 条
[1]
Cao C(2009)A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin Ann Surg Oncol 16 2152-2165
[2]
Yan TD(2002)Peritoneal carcinomatosis from colorectal cancer Br J Surg 89 1545-1550
[3]
Black D(2004)Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study J Clin Oncol 22 3284-3292
[4]
Morris DL(2004)Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials Ann Surg Oncol 11 518-521
[5]
Jayne DG(2013)Peritoneal metastases of lower gastrointestinal tract origin: a comparative study of patient outcomes following cytoreduction and intraperitoneal chemotherapy J Cancer Res Clin Oncol 139 1899-1908
[6]
Fook S(2009)Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin J Clin Oncol 27 681-685
[7]
Loi C(2014)The American Society of Peritoneal Surface Malignancies (ASPSM) multiinstitution evaluation of the peritoneal surface disease severity score (PSDSS) in 1,013 patients with colorectal cancer with peritoneal carcinomatosis Ann Surg Oncol 21 4195-4201
[8]
Seow-Choen F(2008)Swedish experience with peritonectomy and HIPEC. HIPEC in peritoneal carcinomatosis Ann Surg Oncol 15 745-753
[9]
Glehen O(2003)Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer J Clin Oncol 21 3737-3743
[10]
Kwiatkowski F(2018)Safety of intraperitoneal Mitomycin C versus intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis of colorectal cancer undergoing cytoreductive surgery and HIPEC Eur J Surg Oncol 44 220-227